By Fineline Cube 
China-based Yanyin Tech and YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced on September 12, 2025, the establishment of a strategic partnership focused on AI intelligent agents. The collaboration aims to enhance AI applications in new drug development processes.
Collaboration Details
The partnership will leverage Yanyin Tech’s AI Translation Agent project to develop core scenarios for experimental design, IND applications, and AI lab automation robots. This initiative seeks to integrate AI deeply into the entire new drug R&D process, improving efficiency and innovation.
Yanyin Tech’s AI R&D Cloud
Yanyin Tech, a leading molecular biology research platform, offers the “Yanyin AI R&D Cloud,” an enterprise-level collaboration platform powered by AI large models. The AI Translation Agent provides end-to-end solutions for biopharmaceutical documentation, including intelligent translation, model customization, post-editing, and cloud-based management, addressing key industry challenges.
Strategic Vision
Through this collaboration, the companies aim to merge cutting-edge AI technology with practical business applications. Their goal is to enhance drug development efficiency and establish a new industry standard, reflecting a long-term commitment to technological integration and innovation.-Fineline Info & Tech